Respiratory Syncytial Virus (RSV) Vaccine Study

Study Now Open in Cincinnati

Respiratory syncytial virus (RSV) can cause infections of the lungs and respiratory tract. Symptoms can be similar to a cold, and may include runny nose, sore throat, cough, and headache. RSV can lead to serious conditions like pneumonia, especially for people age 60 and older.

While there is currently no approved vaccination to prevent RSV illnesses, scientists are researching an investigational vaccine in this study.

Eligible participants…

  • Must be age 60 or older
  • Will be reimbursed/compensated for travel and expenses
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.

You can also talk to a Meridian enrollment specialist about this study by calling (402) 934-7563.

Submit your information

Expect Excellence icon - supporting research since 1999

Study Location

Meridian Clinical Research

2230 Auburn Avenue, Level B
Cincinnati, OH 45219

Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.